BioStar Capital and Cue Growth co-lead financing to accelerate pivotal trial readiness and expand the ventricular tachycardia (VT) treatment market New board leadership reflects Field's momentum and ...

CARDIFF-BY-THE-SEA, Calif., July 1, 2025 /PRNewswire/ -- Field Medical, Inc., a clinical-stage company redefining cardiac ablation with next-generation pulsed field ablation (PFA) technology, today ...

Field Medical has closed a $35m series B financing round for advancing the development of the FieldForce pulsed field ablation platform. This round was co-led by BioStar Capital and Cue Growth, with ...